I've heard in a while. The tone sounded "confident". I think if medicare doesn't screw over the entire industry and cut reimbursement by some absurd amount like 40% ulgx can do alright. We'll see. Bummer that Boston Sci might be back in the mkt in this qtr, but talk is cheap. Even if they are, things sounded positive for ulgx. Stryker sounds like a guy working a plan, and planning his work. Executing. Would be nice to see break even in the not too distant future.